Introduced
Underlined text would be added to current law. Struck-through text would be removed.
| 89R9891 MPF-D | ||
| By: Kolkhorst | S.B. No. 2336 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to the Texas Pharmaceutical Initiative. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Section 2177.003(a), Government Code, is amended | |
| to read as follows: | |
| (a) The initiative is governed by a board composed of five | |
| [ |
|
| SECTION 2. Chapter 2177, Government Code, is amended by | |
| adding Section 2177.0035 to read as follows: | |
| Sec. 2177.0035. TERMS; VACANCIES. (a) Board members serve | |
| staggered six-year terms, with one-third or as near as possible to | |
| one-third of the members' terms expiring February 1 of each | |
| odd-numbered year. | |
| (b) A vacancy on the board shall be filled for the unexpired | |
| term in the same manner as the original appointment. | |
| SECTION 3. Section 2177.006, Government Code, is amended to | |
| read as follows: | |
| Sec. 2177.006. BUSINESS PLAN. Not later than June 1 of each | |
| even-numbered year [ |
|
| [ |
|
| Legislative Budget Board a business plan on: | |
| (1) implementing the initiative, including the | |
| initiative's organizational structure and related programs; | |
| (2) establishing procedures and policies for the | |
| administration of the initiative, including documenting the | |
| process and resources required for the provision to individuals | |
| described by Section 2177.002 of the following services: | |
| (A) establishing or contracting for statewide | |
| pharmacy benefit manager services; | |
| (B) establishing policies and conditions to | |
| operate or contract for the operation of a distribution network, | |
| central service center, and associated network of satellite | |
| distribution facilities to distribute prescription drugs and | |
| related medical supplies; and | |
| (C) providing advanced pharmaceutical | |
| preparation and related services, including: | |
| (i) manufacturing generic drugs and generic | |
| biological products; | |
| (ii) providing gene therapies and precision | |
| medicine; and | |
| (iii) providing advanced laboratories for | |
| quality control, preparation, and compounding of drugs in support | |
| of innovative therapeutics and drug research; | |
| (3) establishing procedures to document compliance by | |
| board members and personnel with applicable laws governing | |
| conflicts of interest; | |
| (4) establishing the conditions for state agencies | |
| that facilitate health plans to participate in the initiative; | |
| (5) identifying potential cost savings from | |
| implementation of the initiative; | |
| (6) identifying the funding and resources needed to | |
| implement this chapter; and | |
| (7) providing other board recommendations, with | |
| supporting documentation, on continuation of the initiative. | |
| SECTION 4. Section 2177.010, Government Code, is repealed. | |
| SECTION 5. (a) As soon as practicable after the effective | |
| date of this Act, the governor shall appoint the governing board | |
| members for the Texas Pharmaceutical Initiative as required by | |
| Section 2177.003, Government Code, as amended by this Act. | |
| (b) Notwithstanding Section 2177.0035, Government Code, as | |
| added by this Act, in making the appointments of the governing board | |
| members for the Texas Pharmaceutical Initiative under Subsection | |
| (a) of this section, the governor shall designate: | |
| (1) two members to serve terms expiring February 1, | |
| 2027; | |
| (2) two members to serve terms expiring February 1, | |
| 2029; and | |
| (3) one member to serve a term expiring February 1, | |
| 2031. | |
| SECTION 6. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.